Prebet, T., Fenaux, P., & Vey, N. (2016). Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: Validation of the North American MDS consortium scoring system. Haematologica.
Chicago-stil citatPrebet, Thomas, Pierre Fenaux, och Norbert Vey. "Predicting Outcome of Patients With Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica 2016.
MLA-referensPrebet, Thomas, Pierre Fenaux, och Norbert Vey. "Predicting Outcome of Patients With Myelodysplastic Syndromes After Failure of Azacitidine: Validation of the North American MDS Consortium Scoring System." Haematologica 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.